Global Fund Current Affairs - 2019
Category Wise PDF Compilations available at This Link
Hyderabad-based pharma Laurus Labs Limited has announced that it has entered into a strategic partnership agreement with Global Fund for a period of 3.5 years. The agreement gives Laurus Labs volume commitments for drugs from the Global Fund for the treatment of HIV/AIDS.
Global Fund to Fight AIDS, Tuberculosis and Malaria
Global Fund to Fight AIDS, Tuberculosis and Malaria was created in 2002 to raise, manage and invest the world’s money to respond to three of the deadliest infectious diseases the world has ever known. The Global Fund was established with an objective to defeat these three diseases.
AIDS, TB and malaria are all preventable and treatable. The tackling of these disease requires the commitment not only of world leaders and decision-makers but also of those working on the ground to help the men, women and children living with these diseases.
The idea of Global fund was discussed in the G8 summit in Okinawa, Japan, in 2000 and the real commitment began to coalesce at the African Union summit in April 2001. The idea continued doing rounds at the United Nations General Assembly Special Session in 2001 and finally endorsed by the G8 at their summit in Genoa, Italy, in July 2001.
The public sector contributions have constituted 95 per cent of all financing raised by the Global Fund and the remaining 5 per cent came from the private sector or other financing initiatives such as Product Red.
Global Fund aims to attract, leverage and invest additional resources to end the epidemics of HIV/AIDS, tuberculosis and malaria to support attainment of the Sustainable Development Goals established by the United Nations.
Tags: AIDS • G8 summit • Global Fund • Global Fund to Fight AIDS Tuberculosis and Malaria • Italy • Japan • Laurus Labs • Malaria • Sustainable Development Goals • tuberculosis • UNGA • United Nations • United Nations General Assembly
The India Health Fund (IHF) launched by Tata Trusts in collaboration with Global Fund in August 2016 has come forward to financially support innovations and technologies designed to combat tuberculosis (TB) and malaria.
The initiative aims to support new products and strategies that impact entire lifecycle of malaria and TB, from prevention to post-cure recovery. It has recently invited project proposals.
TB and malaria pose long-standing health challenges for India. These two diseases account for over 4.23 lakh deaths and around 15 million lab-confirmed cases every year. The IHF initiative will support individuals and organisations with already germinated innovative strategies, services, products, such that they become sustainable and scalable solutions in addressing TB and malaria.
The initiative is not a fellowship programme to do research from scratch. It is long-term exercise aligned with country’s goal of eliminating TB by 2025 and malaria by 2030. It will promote innovative solutions such that they are widely accessible and are affordable
The four areas of research under it are
- Use of technology and data science to strengthen surveillance of TB and malaria, inform early warning systems and improve early detection and prompt treatment.
- Promote robust molecular diagnostic facilities feasible for primary healthcare in low-resource settings;
- Promote innovations on effective communication strategies that will prevent transmission of malaria and TB and enable people to protect themselves from diseases.
- Research on innovative approaches to vector surveillance.